One more project for #RESAR!
The new #RESAR substudy MATCH is now officially launched!
MATCH will evaluate the agreement between preop surgical planning and intraop practice in RPS and pelvic sarcoma surgery, and its impact on outcomes.
✅Opt-In process is open until October 30.
#RetroperitonealSarcoma
Marco Fiore, MD, FACS, FEBSh retweeted
🌍 Applications are now open for the ESSO–SSO International Career Development Exchange Programme (ICDE).
✅Attend SSO 2027, undertake a US clinical observership, receive dedicated mentorship, and a $3,000 grant.
⏰ Apply by 3 July 2026.
essoweb.org/education/grants…
Proud to announce the new partnership between TARPSWG and @SocSurgOnc !
Together, we aim to advance global #sarcoma care through collaboration, education, and surgeon-led research in #RPS.
Looking forward to new opportunities for the international sarcoma community.
🤖 Made with AI
Registration is now open for the #TARPSWG Semiannual Meeting 2026 in Seoul 🇰🇷
📅 November 18, 2026
📍 Seoul, South Korea
💻 In-person & remote participation available
🔗 Register here: forms.gle/C7sQuZrfwXkSYuvJ8
@ctosociety @SocSurgOnc @SoMe4sarcoma #Sarcoma #RPS #SurgicalOncology
Marco Fiore, MD, FACS, FEBSh retweeted
𝐑𝐄𝐒𝐔𝐑𝐆𝐄 just got more flexible.
ESSO Online Course on Retroperitoneal Sarcoma Surgery now offers replay access — so you can learn live or catch up at your convenience.
🔗 essoweb.org/courses-and-webi…
#RESURGE #ESSO #SarcomaSurgery #Oncology
Interested in #RetroperitonealSarcoma surgery?
Join #ReSurge2026, the @ESSOnews online course endorsed by @TARPSWG community.
@alegronchi @FioreDoc #CarolJSwallow #DirkStrauss
Register here: essoweb.org/courses-and-webi… @IstTumori @SinaiHealth
Highlights include:
• TARPSWG Lecture by Dirk Strauss on the future perspectives opened by prospective #RESAR registry data
• Interactive RE-LIVE surgery sessions from INT Milan and U Toronto Mount Sinai, featuring Carol Swallow, Alessandro Gronchi, Marco Fiore
Marco Fiore, MD, FACS, FEBSh retweeted
📢Abstract deadline extended for #ESSO45
Additional time to finalise and submit your work 👏
🗓 New deadline: 13 May 2026
🔗 esso45.essoweb.org/abstracts…
Marco Fiore, MD, FACS, FEBSh retweeted
⏳ 2 weeks left to submit for #ESSO45
🗓 Deadline: 6 May 2026
🔗 esso45.essoweb.org/abstracts…
#SurgicalOncology
Marco Fiore, MD, FACS, FEBSh retweeted
7-8 maggio a Milano all'@IstTumori: congresso su innovazione, IA, ricerca ed etica in chirurgia oncologica. Posti limitati 👉 arseducandi.it/scheda_congre…
#IstitutoTumoriMilano #Oncologia #Chirurgia #Ricerca #Sanità #Innovazione
Marco Fiore, MD, FACS, FEBSh retweeted
🚀 Call for Young ESSO!
Apply now for one of 4 positions on the Young ESSO Steering Committee (Y-ESSO). Shape education, research & leadership in surgical oncology.
🗓️ Deadline: 17 May 2026
🔗 Apply here: essoweb.org/news-updates/cal…
#ESSO #YoungESSO #SurgicalOncology #EarlyCareer
Marco Fiore, MD, FACS, FEBSh retweeted
Registration is open for the upcoming ESSO Webinar on Head and Neck Sarcoma Management.
A practical session on imaging, resection principles & reconstruction in these complex tumours.
📅 16 Apr 2026
🕔 17:00 CEST
🔗 Register: essoweb.org/courses-and-webi…
#Sarcoma #HeadAndNeckSurgery
Il 7-8 maggio a Milano l'evento organizzato dal Dipartimento di Chirurgia Oncologica di @IstTumori "LA SFIDA DELLA CHIRURGIA ONCOLOGICA TRA TECNICA, RICERCA E ORGANIZZAZIONE"
#surgicaloncology da punto di vista molto interessante, e trasversale rispetto alle singole discipline
Iscrizione gratuita qui: arseducandi.it/scheda_congre…
Master in Sarcoma run by ESO
linkedin.com/posts/european-…
Marco Fiore, MD, FACS, FEBSh retweeted
Building on terrific #SSO2026 and @TARPSWG meetings, check out our📄on current dx & tx strategies for soft tissue sarcoma @BjsOpen, including recent technical advances and multiD approaches
@ctosociety @SocSurgOnc @ESSOnews @_CSSO @FioreDoc @alegronchi
academic.oup.com/bjsopen/art…
Diagnosis and treatment of primary soft tissue sarcomas: comprehensive review
➡️doi.org/10.1093/bjsopen/zraf…
This review outlines current diagnostic and treatment strategies for localized primary soft tissue sarcomas, with a separate focus on extremity/trunk and retroperitoneal disease. Key points include recent therapeutic advances, multidisciplinary management, and the centralization of care in high-volume centres to optimize outcomes.
👏👏👏Fahima Dossa , Eldad Elnekave , Aisha B Miah , Catherine Mitchell , Sarah Watson , @alegronchi , @FioreDoc
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @BJSAcademy @BJSurgery


















